Effective April 28, 2021:
The U.S. Department of Health & Human Services (HHS) has published new practice guidelines regarding buprenorphine prescribing for opioid use disorder. New guidelines state:
Eligible providers can now treat up-to 30 patients without completing previously required training
Qualified providers include physicians, physician assistants, and advanced practice nurses – all you need is a valid medical license and Drug Enforcement Administration (DEA) registration
To treat more than 30 patients, providers need to undergo required training – click here to find a training near you
For more information, please see SAMHSA’s FAQ page.
1. Check your eligibility
Based on license and number of patients you will treat
2. Complete your notification form
Follow the prompts & read carefully
3. Submit your notification
You will receive a confirmation OR an error message
Note: A DEA-registered practitioner working in a hospital, clinic, or emergency room, or any DEA-registered hospital/clinic that allows practitioners to operate under their registration number as per 21 CFR 1301.22(c), may request an exception to the one-day supply limitation currently imposed pursuant to 21 CFR 1306.07(b). Consistent with Pub. L. 116-215, DEA will grant such requests to allow a practitioner to dispense up to a three-day supply of the medication under the circumstances described in subsection 1306.07(b).
Requests for exception must be emailed to: ODLP@dea.gov. Please add the following to the subject line: Request for Exception to Limitations on Dispensing for OUD.